Journal of Transplantation · 2012 · 14 citations · 22 references
Life SciencesImmunologyNephrologyImmunotherapyKidney TransplantationTransplant ImmunologyAcute RejectionAllograft RejectionImmunosuppressionImmunosuppressive TherapyInduction ImmunosuppressionTransplant RejectionBasiliximab InductionDelayed Graft Function PreventionImmunosuppression RegimensKidney Transplant ImmunosuppressionPharmacologic ImmunosuppressionPost-transplant ImmunosuppressionRenal Transplant RejectionTreatment Of Rejection Episodes
Dual induction with low doses of rabbit anti-human thymoglobulin (RATG) and basiliximab effectively and safely prevented allograft rejection in high-risk renal transplant recipients. To assess whether treatment timing affects efficacy and tolerability, in this single-center, matched-cohort study, we compared posttransplant outcomes in 25 patients and 50 gender-, age-, and treatment-matched reference patients induced with the same course of 7 daily RATG infusions (0.5 mg/kg/day) started before or after engraftment, respectively. All subjects received basiliximab (20 mg) before and 4 days after transplantation, withdrew steroids within 6 days after surgery, and were maintained on steroid-free immunosuppression with cyclosporine and mycophenolate mofetil or azathioprine. Over 12 months after transplant, 1 patient (4%) and 13 reference patients (26%) had acute rejection episodes. One patient and 5 reference-patients required dialysis therapy because of delayed graft function. In all patients circulating CD4+ and CD8+ T lymphocytes were fully depleted before engraftment. Both treatments were well tolerated. In kidney transplantation, perioperative RATG infusion enhances the protective effect of low-dose RATG and basiliximab induction against graft rejection and delayed function, possibly because of more effective inhibition of early interactions between circulating T cells and graft antigens.
22
Rabbit Antithymocyte Globulin versus Basiliximab in Renal Transplantation
Daniel C. Brennan, John A. Daller, Kathleen D. Lake et al. · New England Journal of Medicine · 2006 · 730 citations · Full text
Medicine, Nephrology, Pharmacology +17
Immunosuppression: Evolution in Practice and Trends, 1994–2004
H.-U. Meier-Kriesche, S. Li, Rainer W.G. Gruessner et al. · American Journal of Transplantation · 2006 · 558 citations · Full text
A Novel Mechanism of Action for Anti-Thymocyte Globulin
Marta Lopez, Michael R. Clarkson, Monica Albin et al. · Journal of the American Society of Nephrology · 2006 · 367 citations
A. Osama Gaber, M. Roy First, Raymond J. Tesi et al. · Transplantation · 1998 · 301 citations